Kimyrsa 1200 mg/40mL
oritavancin diphosphate · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Melinta Therapeutics, LLC
Kimyrsa is a injection, powder, lyophilized, for solution containing oritavancin diphosphate at 1200 mg/40mL, taken intravenous. Manufactured by Melinta Therapeutics, LLC.
Key Facts
- Brand Name
- Kimyrsa
- Generic Name
- oritavancin diphosphate
- NDC Code (Product)
70842-225- Manufacturer
- Melinta Therapeutics, LLC
- Strength
- 1200 mg/40mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA214155
- Marketing Start
- 03/23/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is Kimyrsa used for?
Kimyrsa contains oritavancin diphosphate. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is Kimyrsa a controlled substance?
Kimyrsa is not classified as a controlled substance by the DEA.
What is the generic name for Kimyrsa?
The generic name for Kimyrsa is oritavancin diphosphate. There are no other listed brand versions of oritavancin diphosphate.
What is the NDC code for Kimyrsa 1200 mg/40mL?
The NDC (National Drug Code) for Kimyrsa 1200 mg/40mL is 70842-225, listed by Melinta Therapeutics, LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)